Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes. [electronic resource]
Producer: 20090713Description: 105-12 p. digitalISSN:- 1879-0712
- Action Potentials -- drug effects
- Angiotensin II -- pharmacology
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Animals
- Animals, Newborn
- Benzimidazoles -- pharmacology
- Benzoates -- pharmacology
- Calcium Channels, T-Type -- genetics
- Cells, Cultured
- Dose-Response Relationship, Drug
- Drug Interactions
- Electrophysiology
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- F-Box Proteins
- Flavonoids -- pharmacology
- Gene Expression Regulation -- drug effects
- Heart Rate -- drug effects
- Imidazoles -- pharmacology
- JNK Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Membrane Potentials -- drug effects
- Myocytes, Cardiac -- drug effects
- Patch-Clamp Techniques
- Pyridines -- pharmacology
- RNA, Messenger -- metabolism
- Rats
- Rats, Wistar
- Telmisartan
- Tetrazoles -- pharmacology
- Time Factors
- Valine -- analogs & derivatives
- Valsartan
- Zebrafish Proteins
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.